Related Experiment Video
Updated: Sep 19, 2025

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Weight-Related Outcomes Among Survivors of Adolescent and Young Adult Cancer after Anti-Obesity Medication Initiation
Amy M Berkman1, Clark R Andersen2, Stephanie B Dixon1
1Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Abstract:
Anti-obesity medications (AOMs) have not been studied in survivors of adolescent and young adult (AYA) cancer. In this retrospective analysis, generalized additive mixed model with penalized spline described body mass index (BMI) over time among survivors of AYA cancer prescribed an AOM. Body weight and BMI at pre-AOM maximum and last follow-up were summarized, with 95% confidence intervals. Over a median follow-up time of 249 days, 63.4% of survivors had ≥5% weight reduction. The proportion of survivors with severe obesity decreased from 60% to 35%. These findings suggest that AOMs are effective for weight reduction in survivors of AYA cancer.
Related Concept Videos
Obesity
Cancer Survival Analysis
Treatment Resistant Cancers
Cancer Prevention
Some...
Bulimia Nervosa
Anorexia Nervosa
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...

